Lee Chin Hyok
SEC insider (Form 3/4/5 filer). CIK 0002010805. Chief Medical Officer at Lycia Therapeutics, Inc. (LYCA) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Lee Chin Hyok has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): Officer, 10% Owner, Chief Medical Officer
- Allakos Inc. (ALLK): Officer, Chief Medical Officer
Lee Chin Hyok
CIK: 0002010805
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
